Paul Dodd
Direktor/Vorstandsmitglied bei Merck Sharp & Dohme (Holdings) Pty Ltd.
Profil
Paul Dodd is currently a Director at Merck Sharp & Dohme (Holdings) Pty Ltd.
He was formerly a Director at Viralytics Pty Ltd.
Aktive Positionen von Paul Dodd
| Unternehmen | Position | Beginn |
|---|---|---|
Merck Sharp & Dohme (Holdings) Pty Ltd.
 Merck Sharp & Dohme (Holdings) Pty Ltd. MiscellaneousMiscellaneous Merck Sharp & Dohme (Holdings) Pty Ltd. operates as an investment holding company. The company is headquartered in Macquarie Park, Australia. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Paul Dodd
| Unternehmen | Position | Ende |
|---|---|---|
| VIRALYTICS LTD. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
Merck Sharp & Dohme (Holdings) Pty Ltd.
Merck Sharp & Dohme (Holdings) Pty Ltd. MiscellaneousMiscellaneous Merck Sharp & Dohme (Holdings) Pty Ltd. operates as an investment holding company. The company is headquartered in Macquarie Park, Australia. | Miscellaneous |
